A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
The pilot sets a flat copay for eligible beneficiaries as CMS seeks a longer-term way to cover costly obesity drugs.
3 Articles
3 Articles
A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It’s a notable shift for Medicare, which has long been barred from covering weight loss treatments. The drugs, such as Wegovy and Zepbound, are effective but can be expensive without insurance coverage. They’re available in injection or pill form. Even with discounts, current cash prices typically range from $149 to $699 per month. A…
Medicare Program to Offer GLP-1 Drugs for $50 Per Month Starting in July
Fact checked by Jennifer KlumpThe new Medicare GLP-1 Bridge program will cover GLP-1 drugs for weight loss for eligible beneficiaries.Credit: Peter Dazeley / Getty ImagesKey TakeawaysThe Medicare GLP-1 Bridge program will cover weight loss drugs for a $50 monthly copay for eligible beneficiaries through Dec. 31, 2027.Medicare currently does not cover GLP-1 drugs for weight loss alone.Eligible patients must meet BMI and health criteria and obtain…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
